HbA1c, Fructosamine and Glycaemic Monitoring
On this page
Direct answer
HbA1c is glycated haemoglobin, reflecting average blood glucose over roughly the preceding two to three months, and it is the standard test for monitoring diabetes. Its accuracy falls in anaemia, haemolysis, recent transfusion and haemoglobin variants, when fructosamine becomes the alternative. Fructosamine reflects glycaemia over about two to three weeks, because it measures glycated serum proteins, mainly albumin.
What you must remember
- Reflects: glycated haemoglobin over about two to three months, weighted towards the most recent weeks because red cells age gradually.
- Usual target: many adults with diabetes aim for below about 7 per cent, although the target varies with age, hypoglycaemia risk and comorbidity.
- Falsely low: haemolysis, blood loss, recent transfusion and erythropoietin therapy shorten red-cell exposure and lower HbA1c.
- Falsely high: iron deficiency raises HbA1c because older red cells persist, and carbamylated haemoglobin in renal failure can interfere with some assays.
- Haemoglobin variants: HbS, HbC, HbE and thalassaemia can distort HbA1c depending on the assay, which is why an alternative test is sometimes needed.
- Fructosamine: glycated serum proteins reflecting roughly two to three weeks, falsely low when albumin is low, as in nephrotic syndrome.
- Self-monitoring: capillary glucose guides day-to-day insulin adjustment and hypoglycaemia detection, while continuous monitoring shows nocturnal lows and variability.
A monitoring pathway that respects the red cell
A 56-year-old man with type 2 diabetes has an HbA1c of 6.2 per cent, yet his home glucose readings are high and he has been transfused for anaemia last month. The result cannot be taken at face value. The steps below show how to choose the right tool for the question.
- Start with HbA1c: Check at diagnosis, then about every three months while treatment is being adjusted, and at least six-monthly once control is stable.
- Screen for red-cell disorders: Ask about anaemia, haemolysis, transfusion, kidney disease and erythropoietin therapy before trusting the value.
- Switch to fructosamine when HbA1c misleads: Use it for short-term assessment after a regimen change or when the red cell is abnormal.
- Correct for albumin: Interpret fructosamine cautiously when serum albumin is low, because a low value may underestimate glycaemia.
- Use capillary glucose for dosing: Self-monitoring guides insulin dose changes and detects hypoglycaemia, especially in insulin-treated patients.
- Consider continuous monitoring: Continuous glucose monitoring reveals nocturnal hypoglycaemia and glycaemic variability that HbA1c cannot show.
Where the exam tries to catch you
The common errors come from trusting one number when the red cell or the protein pool has changed.
- Trap: trusting HbA1c after a recent transfusion or in iron-deficiency anaemia Correct: transfusion usually lowers the value while iron deficiency raises it, so fructosamine or glucose profiles give a truer picture.
- Trap: reading a low fructosamine as good control in nephrotic syndrome Correct: hypoalbuminaemia lowers fructosamine, so the result underestimates glycaemia.
- Trap: applying one HbA1c target to every patient Correct: targets depend on age, hypoglycaemia risk and comorbidity, so tighter targets are not always safe.
Frequently asked questions
Why can HbA1c be misleading in iron deficiency anaemia?
HbA1c can be misleading in iron deficiency anaemia because iron deficiency leads to older circulating red cells, which have had longer exposure to glucose. The HbA1c therefore rises without a true rise in average glucose. The value should be interpreted alongside the haematological picture and, if needed, fructosamine.
What does fructosamine measure in glycaemic monitoring?
Fructosamine measures glycated serum proteins, mainly albumin, and reflects glycaemia over roughly the preceding two to three weeks. It is useful when HbA1c is unreliable or when a short-term change in therapy needs assessment. Low albumin, as in nephrotic syndrome, lowers fructosamine and must be considered.
What HbA1c target is commonly used for adults with diabetes?
Many adults with diabetes aim for an HbA1c below about 7 per cent, although individual targets depend on age, hypoglycaemia risk and comorbidity. Stricter targets are not always appropriate in elderly or frail patients. The target should be set jointly with the patient.
How often should HbA1c be checked in diabetes?
HbA1c is usually checked about every three months while treatment is being adjusted, then at least every six months once control is stable. Additional checks follow a change in therapy or an unexplained difference between laboratory and home glucose readings. The frequency should match the clinical situation rather than a fixed rule.
Which conditions falsely lower HbA1c?
Conditions that shorten red-cell survival, such as haemolysis, blood loss and recent transfusion, falsely lower HbA1c. Erythropoietin therapy also lowers it by increasing the proportion of young red cells. In these settings, fructosamine or capillary glucose profiles give a more reliable picture of glycaemia.